US FDA Commissioner Scott Gottlieb announced on Feb. 28 that the agency is re-examining whether federal licensing laws for wholesalers and third-party logistics providers should be allowed to fully preempt state law under Section 205 of the Drug Supply Chain Security Act (DSCSA).
Speaking at FDA’s third public workshop on DSCSA implementation at its headquarters in White Oak, Md., Gottlieb also announced FDA’s...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?